RxDoctor Payments Data

Carleton Vangsness

Sports Medicine · Los Angeles, CANPI 1609829746

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $770,478 of the $872,117 with a category attached, or 88.3%. Anika Therapeutics, Inc. accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $770,478 and has fallen 86.9% since, to $100,871 in 2022. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$872,117in general payments, 2019–2025

Across 7 payments — averaging $124,588 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Anika Therapeutics, Inc.$871K
  • Bioventus LLC$700
  • Smith+Nephew$47
  • Kinamed, Inc.$21

What the payments were for

  • Consulting fees$7000%
  • Food & beverage$680%
  • Ownership interest$770,47888%
  • Other$100,87112%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Anika Therapeutics, Inc.4$871,349
Bioventus LLC1$700
Smith+Nephew1$47
Kinamed, Inc.1$21

How this compares

$872,117 in reported general payments places this provider in the 95th percentile of 662 sports medicine providers in California.

See all sports medicine providers in California →

Other sports medicine in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →